Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
Recursion Pharmaceuticals, Inc. Income Statement Banner

Recursion Pharmaceuticals, Inc. Income Statement

RXRX Stock Analysis

Page title

Section title

Breakdown
2019
2020
2021
2022
2023
Total Revenue
1.711M3.413M10.000M39.681M44.575M
Cost of Revenue
45.809M63.319M9.104M48.275M42.587M
Gross Profit
-44.098m-59.906m896.000K-8.594m1.988M
Operating Expense
64.152M88.028M192.775M237.133M352.048M
Operating Income
-62.441m-84.615m-182.775m-245.727m-350.060m
Other Income Expense
-608.000k-549.000k-178.000k-162.000k0.000
Total Other Income Expense
562.000K-2.391m-3.704m6.251M17.932M
Pretax Income
-61.879m-87.006m-186.479m-239.476m-332.128m
Tax Provision
646.000K876.000K-8.405m-55.000k-4.062m
Net Income
-62.525m-87.882m-178.074m-239.421m-328.066m
Basic EPS
-0.373-0.525-1.050-1.360-1.580
Diluted EPS
-0.373-0.525-1.050-1.360-1.580
Basic Average Shares
165.791M165.791M170.272M175.537M207.854M
Diluted Average Shares
165.791M165.791M170.272M175.537M207.854M
Total Expenses
64.152M88.028M192.775M285.408M394.635M
Interest Income
1.741M336.000K73.000K6.254M19.116M
Interest Expense
635.000K1.360M2.952M55.000K97.000K
EBITDA
-58.336m-81.703m-174.423m-227.665m-299.566m
Depreciation & Amortization
3.543M4.442M9.104M19.486M24.402M